Inspirata

Caradigm specializes in intelligent healthcare analytics and population health management solutions. The company provides an enterprise platform that includes visual analytics and care management services, all hosted in the cloud. These offerings are designed to assist healthcare organizations in enhancing patient care, minimizing costs, and effectively managing risk. By delivering insights into patients, populations, and overall performance, Caradigm aims to support healthcare providers in navigating the complexities of modern healthcare delivery.

Omnyx, LLC is a joint venture between GE Healthcare and UPMC, with operations based in Pittsburgh, PA, and Piscataway, NJ. The company specializes in digital pathology solutions, particularly the Omnyx IDP system, which facilitates an all-digital workflow for pathology departments worldwide. Omnyx offers a range of products, including image acquisition devices, workflow software, and consulting services aimed at transforming cancer care. By closely collaborating with pathologists at UPMC and other institutions, as well as leveraging its relationship with GE Healthcare, Omnyx focuses on addressing the specific needs of anatomic pathologists globally. Its products are designed for in vitro diagnostic use in particular clinical applications, while also allowing for research use in other areas.

Artificial Intelligence in Medicine, Inc. is a Toronto-based software engineering firm that specializes in developing tools that utilize artificial intelligence (AI) and natural language processing (NLP) to enhance healthcare delivery, particularly in cancer control. The company focuses on extracting relevant information from various clinical documents, including pathology reports and treatment plans, to support medical research and disease prevention efforts. By designing and deploying advanced information systems, Artificial Intelligence in Medicine aims to improve healthcare services and patient outcomes in the oncology sector. Incorporated in 1983, the firm operates as a subsidiary of Inspirata, Inc., continuing its commitment to integrating informatics into healthcare solutions.

Precision Medicine Network, Inc. is a company that specializes in a knowledge visualization and decision support platform aimed at enhancing the adoption of precision medicine. Founded in 2011 in Concord, Massachusetts, the company emerged from the Genomic Medicine Initiative at Harvard Medical School. Its platform, known as Crosswalk Insight™: Oncology, is designed to facilitate the integration of precision medicine into clinical practice. The platform serves a diverse range of users, including oncologists, pathologists, pharmaceutical companies, clinical trial developers, and healthcare executives, among others. By providing resources such as tumor images, molecular pathways, and clinical research, Precision Medicine Network aims to bridge gaps between providers, patients, and payers to realize the full potential of precision healthcare. As of 2016, it operates as a subsidiary of Inspirata, Inc.